These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16328031)

  • 1. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue.
    Kwon MS; Kim SJ; Lee SY; Jeong JH; Lee ES; Kang HS
    Oncol Rep; 2006 Jan; 15(1):27-32. PubMed ID: 16328031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG methylation of the ERalpha and ERbeta genes in breast cancer.
    Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS
    Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer.
    Kim SJ; Kang HS; Chang HL; Jung YC; Sim HB; Lee KS; Ro J; Lee ES
    Oncol Rep; 2008 Mar; 19(3):663-8. PubMed ID: 18288399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
    Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
    Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
    Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
    Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of the THRB gene in tissue and plasma of breast cancer patients.
    Ling Y; Xu X; Hao J; Ling X; Du X; Liu X; Zhao X
    Cancer Genet Cytogenet; 2010 Jan; 196(2):140-5. PubMed ID: 20082849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
    Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
    Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.
    Noetzel E; Rose M; Sevinc E; Hilgers RD; Hartmann A; Naami A; Knüchel R; Dahl E
    Oncogene; 2010 Aug; 29(34):4814-25. PubMed ID: 20543860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epigenetic inactivation of microRNA genes in mammary carcinoma].
    Lehmann U; Hasemeier B; Römermann D; Müller M; Länger F; Kreipe H
    Verh Dtsch Ges Pathol; 2007; 91():214-20. PubMed ID: 18314617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of gene promoter hypermethylation in fine needle washings from breast lesions.
    Jerónimo C; Costa I; Martins MC; Monteiro P; Lisboa S; Palmeira C; Henrique R; Teixeira MR; Lopes C
    Clin Cancer Res; 2003 Aug; 9(9):3413-7. PubMed ID: 12960130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.
    Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
    Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel methylation and expression markers associated with breast cancer].
    Kuznetsova EB; Kekeeva TV; Larin SS; Zemliakova VV; Babenko OV; Nemtsova MV; Zaletaev DV; Strel'nikov VV
    Mol Biol (Mosk); 2007; 41(4):624-33. PubMed ID: 17936981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
    Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
    Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
    Rønneberg JA; Tost J; Solvang HK; Alnaes GI; Johansen FE; Brendeford EM; Yakhini Z; Gut IG; Lønning PE; Børresen-Dale AL; Gabrielsen OS; Kristensen VN
    Cancer Res; 2008 Jul; 68(14):5562-71. PubMed ID: 18632608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
    Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
    Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.